Nutrition for Asthmatics with Obesity
Nutritional Strategies to Enhance Lung Function in Asthmatics with Obesity
1 other identifier
interventional
10
1 country
1
Brief Summary
This study will test the effect of diet on asthma in individuals with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Jun 2022
Typical duration for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2022
CompletedFirst Posted
Study publicly available on registry
February 3, 2022
CompletedStudy Start
First participant enrolled
June 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 4, 2025
January 1, 2025
2.5 years
January 5, 2022
February 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Asthma Control
Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.
Baseline
Asthma Control
Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.
After 7 days on Diet#1
Asthma Control
Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.
After 7 days on Diet#2
Asthma Control
Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.
After 7 days on Diet#3
Secondary Outcomes (12)
Lung Function
Baseline
Lung Function
After 7 days on Diet#1
Lung Function
After 7 days on Diet#2
Lung Function
After 7 days on Diet#3
FENO
Baseline
- +7 more secondary outcomes
Study Arms (3)
Dietary Guidelines for Americans
EXPERIMENTAL7 days of a diet consistent with the Dietary Guidelines for Americans (DGA).
Medium Chain Triglyceride Supplemented DGA
EXPERIMENTAL7 days of a diet consistent with the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).
Ketogenic Diet
EXPERIMENTAL7 days of a ketogenic diet (KETO).
Interventions
A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA) Including: * A variety of vegetables and fruits * Grains, at least half of which are whole grains * Fat-free or low-fat dairy * A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds * This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.
A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).
Eligibility Criteria
You may qualify if:
- Age: 18-65 years
- BMI: 30-45 kg/m2
- asthma diagnosed by medical specialist (confirmed in medical history)
- partly controlled or uncontrolled asthma by Asthma Control Test score ≤22
- owns a device compatible with ZEPHYRx platform
- stable asthma medication use (no change in the past 2 months).
You may not qualify if:
- Diabetes or using diabetes medications that may lower blood glucose levels
- point of care fasting blood glucose ≥126 mg/dl or triglycerides ≥400 mg/dl
- current smoking or smoking history of greater than 10 pack-years
- other significant respiratory or cardiac disease or the presence of clinically important comorbidities, e.g., COPD, renal failure, liver disease; uncontrolled hypertension defined as systolic blood pressure ≥160 mm/Hg, or diastolic blood pressure ≥100 mm/Hg
- pregnant or nursing women
- food preferences or allergies inconsistent with study diet capabilities
- noncompliance with lead-in period requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pennington Biomedical Research Centerlead
- The Cleveland Cliniccollaborator
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacob T Mey, PhD, RD
Pennington Biomedical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants will not be made aware of the diet allocation. However, due inherent differences in macronutrient content of the diets, participants may perceive differences in the quantity of various food groups or in the taste, texture or smell of foods present in the diet. To address this, diets will be designed to minimize noticeable differences for the participant. The investigator and outcomes assessor will remain fully masked to diet provision.
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 5, 2022
First Posted
February 3, 2022
Study Start
June 27, 2022
Primary Completion
December 18, 2024
Study Completion
December 31, 2024
Last Updated
February 4, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Study data will be provided upon request and approval by study PI.